Protecting now from what comes next

The outbreak of COVID-19 caught the world off guard and severely constrained people's ability to live their lives to the fullest. Responses have been very broad (such as social distancing) or targeting specific strains (such as vaccines). And while crucial and developed at unprecedented speed, all responses are reactive.

What the world needs is a proactive approach. Nature harbors millions of unknown viruses and with virus mutations in humans, new infections are a given. However, we don’t know which one will strike next. The current reactive approach does not prepare us for these future threats.

It’s time for a new approach

divider-L-1

Love Hugs

divider-L_2

our new Approach

Leyden Labs’ proactive approach protects against a broad range of viruses

To protect from what comes next, we need to act proactively and be ready for a broad range of viruses. At Leyden Labs, we enable this by developing our platform and products with three innovative concepts:

Targeting the commonalities of viruses

The millions of unknown viruses harbored in nature can be grouped in a few dozen of viral families. By targeting the commonalities of these families, we can develop protection against entire virus families at once, including the unknown variants. Our focus is on respiratory viruses like influenza and coronaviruses, which are most likely to cause pandemics because they are transmitted through the air.

Attacking viruses where they attack us

Through our platform, we are developing nasal sprays that provide immediate protection because they attack viruses where they attack us – in our nasal passages – keeping people safe from catching infections and preventing people from spreading them to others.

Providing people the freedom to protect themselves

We are working toward accessible, self-administrable products, so people can take control and live their lives to the fullest by protecting themselves against catching infections and preventing transmission to others.

divider-L-1

Love Sports

divider-L_2

our team

We challenge limits

The city of Leiden (The Netherlands) inspired our name. For centuries, Leiden is known for unconventional thinking, the freedom to express this openly and scientific breakthroughs such as the first publications of Galileo’s famous Discorsi.

Our team of energetic, experienced and curious people is ready to go beyond to accomplish our mission. We strive for a fantastic life for all people. We aim for the highest, think unconventionally and focus relentlessly on delivering the impossible. In our team trust, integrity and inclusiveness are a given.

Our team

Meet our team and discover how they live their lives to the fullest.

LL-Koenraad

Koenraad Wiedhaup

Founder and CEO

LL-Jaap-Goudsmit

Jaap Goudsmit

Founder and Chief Scientific Officer

LL-Ronald-Brus

Ronald Brus

Founder and Chief Business Officer

LL-Anne

Anne van Loon

Strategy & BD

LL-WouterKoudstaal

Wouter Koudstaal

Discovery

LL-Bertjan

Bertjan Ziere

Pre-clinical

LL-Danielle

Danielle Kool

Business Strategy

LL-Dennis

Dennis de Vlaam 

Head of Operations

LL-Sarka

Sarka Bejckova

People & Operations

LL-Tom

Tom Razoux Schultz

Analytics lead

LL-Peter-T

Peter Tjeerdsma

CMC Expert

LL-Albertjan

Albert Jan van Soelen

General Counsel

LL-FonsUytdehaag

Fons Uytdehaag

Development project manager

LL-PeterRottier

Peter Rottier

Scientific advisor

LL-Vivianne

Vivian Bouwer

Office Manager

Our Supervisory Board

LL-Dinko

Dinko Valerio

Founder and Executive Chair

SB-John-Martin

John Martin - In memoriam

Former CEO Gilead Sciences

SB-Onno

Onno van de Stolpe

CEO Galapagos

SB-James-Shannon

James Shannon

Former CMO GSK and Global Head of Development at Novartis

SB-Richard_Whitley

Richard Whitley

Professor in Pediatrics and Microbiology, Medicine and Neurosurgery at University of Alabama

SB-david-schenkein

David Schenkein

General Partner GV

SB-Stephen-Knight

Stephen Knight

President and Managing
Partner 
F-Prime Capital

Our investors

We are working together with GV (formerly Google Ventures), F-Prime Capital and Casdin Capital and private investors such as Brook Byers. Please do not hesitate to reach out if you are interested in partnering with us.

GV_logo
F-Prime
Casdin

our values

join our mission

Become part of our journey

At Leyden Labs, we want to free humanity from the burden of respiratory viruses to let people live life to the fullest. We are moving fast and growing quickly. Are you interested in contributing?

Partners

We work closely together with academics, commercial researchers and other commercial parties to further develop our business.

Institutions and Governments

We aim to prepare society for future pandemics and are keen to help governments and institutions do so.

Investors

We are open to discussions with interested investors.

People

We are growing quickly and always looking for the best people to work with.

divider-L-1

Love Life

divider-L_2
LL-Blue

Adress

Keizersgracht 290 A
1016 EW Amsterdam
The Netherlands

Locations

Amsterdam
Boston


Stay updated

© Leyden Labs, 2021  |  Privacy Policy  |  Design by Ape to Zebra

Back to top Arrow